Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol (DEMOB)
- 1 January 1986
Abstract
A 3.5‐year‐old boy with a multifocal primary lymphoma of the brain was treated successfully without neurotoxicity with a treatment regimen that did not include radiation. The protocol of Dexacort (dexamethasone), methotrexate, Oncovin (vincristine), and BCNU (carmustine) (DEMOB), which was developed with the use of MTX pharmocokinetic studies, was given over 7.5 months, and resulted in tumor disappearance on computerized tomography scans and marked improvement in clinical status. The patient remains in good health 3 years after diagnosis (March 1985).This publication has 27 references indexed in Scilit:
- Lymphoma after organ transplantation: radiologic manifestations in the central nervous system, thorax, and abdomen.Radiology, 1983
- Spontaneous regression of intracerebral lymphoma.Radiology, 1983
- Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 casesCancer, 1983
- Prediction of BCNU Pulmonary Toxicity in Patients with Malignant GliomasNew England Journal of Medicine, 1980
- The use of proteolytic enzymes to improve immunoglobulin staining by the PAP techniqueJournal of Molecular Histology, 1979
- An immunohistological study of immunoglobulin content of primary central nervous system lymphomasCancer, 1978
- Competitive protein binding assay for methotrexate.Proceedings of the National Academy of Sciences, 1975
- Reticulum cell sarcoma of the brain.A review of the literature and a study of 19 casesCancer, 1975
- Radiation Therapy for Intracranial LymphomaRadiology, 1967
- Neoplasms of the reticuloendothelial system of the brainCancer, 1963